TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15042800

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study: 10874656

Group type: EXPERIMENTAL
Intervention: Suprathreshold concentrations of phenyl ethyl alcohol (PEA)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Suprathreshold concentrations of pyridine (PYR)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Odor detection thresholds for PEA and PYR
Number of subjects: 89
Study: 9496213

Group type: EXPERIMENTAL
Intervention: Soda lime with 60 ml of water added (water group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Partly exhausted soda lime (carbon dioxide group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fresh soda lime (control group)
Number of subjects: 24
Study: 8201800

Group type: EXPERIMENTAL
Intervention: Zopiclone (ZPC) 10 mg
Number of subjects: 7
Study: 3815141

Group type: EXPERIMENTAL
Intervention: Post-by-pass hemoconcentration
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no hemoconcentration)
Number of subjects: 80
Study: 30924581

Group type: EXPERIMENTAL
Intervention: Narrative intervention group
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Vocabulary intervention group
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Combined narrative and vocabulary intervention group
Number of subjects: 358

Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 358
Study: 28711725

Group type: EXPERIMENTAL
Intervention: Patient-centred pressure ulcer prevention care bundle
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1598
Study: 24903544

Group type: EXPERIMENTAL
Intervention: AFXL-PDT
Number of subjects: 32

Group type: COMPARATOR
Intervention: PDT
Number of subjects: 32
Study: 23907087

Group type: EXPERIMENTAL
Intervention: Rectal stimulation and/or small volume enemas
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (rectal stimulation/enemas)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDA presence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDA
Number of subjects: 0
Study: 21533739

Group type: EXPERIMENTAL
Intervention: Ear acupuncture at tender points located in area M, positive to Needle Contact Test (NCT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Ear acupuncture at unsuitable area S
Number of subjects: 94
Study: 19118966

Group type: EXPERIMENTAL
Intervention: Mesalazine 50mg/kg per day
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Mesalazine in medication stratum
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Mesalazine in nutrition stratum
Number of subjects: 122
Study: 17562631

Group type: EXPERIMENTAL
Intervention: Virtual reality distraction intervention during chemotherapy
Number of subjects: 123

Group type: COMPARATOR
Intervention: No intervention (control) during matched chemotherapy treatment
Number of subjects: 123
Study: 15319676

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E (300 microg of each antigen B and E)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: gp120 B/E
Number of subjects: 0
Study: 11439380

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: SNAP index
Number of subjects: 67
Study: 9934894

Group type: EXPERIMENTAL
Intervention: Optimistic survival forecasts
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pessimistic survival forecasts
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Perceived benefit
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Practice style
Number of subjects: 120
Study: 7753947

Group type: EXPERIMENTAL
Intervention: Incidental test with graphemic processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Opposition test with graphemic processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidental test with semantic processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Opposition test with recognition failure conditionalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidental and opposition tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intentional test
Number of subjects: 0
Study: 2147241

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Local/regional anaesthesia
Number of subjects: 64
Study: 6986409

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bilateral surgical adrenalectomy
Number of subjects: 0
Study: 31991566

Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Immunonutrition in PDAC patients
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Immunonutrition in non-PDAC patients
Number of subjects: 70
Study: 30916579

Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Soft-Tissue Mobilization (IASTM) using the Graston technique
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conservative care
Number of subjects: 11
Study: 28503750

Group type: EXPERIMENTAL
Intervention: Liraglutide 3 mg daily for 26 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Structured lifestyle modification (dieting restriction by 400 kilocalories/d plus moderate-intensity aerobic exercise 200 min/wk) for 26 weeks
Number of subjects: 24
Study: 26628206

Group type: EXPERIMENTAL
Intervention: Clinical Case Management integrated with Problem-Solving Therapy (CM-PST)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Clinical Case Management (CM)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Both interventions (CM and CM-PST)
Number of subjects: 171
Study: 23313304

Group type: EXPERIMENTAL
Intervention: PANSS pentagonal model (PM)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Van Der Gaag 5-factor model (VDG)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Correlation analyses between PM and VDG models
Number of subjects: 108
Study: 21523719

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study: 19848049

Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 24
Study: 16763658

Group type: EXPERIMENTAL
Intervention: Akreos Fit IOL (two-point haptic)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Akreos Adapt IOL (four-point haptic)
Number of subjects: 93
Study: 12690054

Group type: EXPERIMENTAL
Intervention: L-dopa treatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: STN stimulation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined treatment (L-dopa + STN stimulation)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-dopa, STN stimulation, and combined treatment
Number of subjects: 8
Study: 11050641

Group type: EXPERIMENTAL
Intervention: Numerical postprocessing technique for MR images
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Standardized dual fast spin-echo MR images
Number of subjects: 10
Study: 8863019

Group type: EXPERIMENTAL
Intervention: Wheat bran
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Senna
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 40
Study: 1736456

Group type: EXPERIMENTAL
Intervention: Nicotine patch (15 +/- 3.5 mg of nicotine in 16 hours)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 289
Study: 6845123

Group type: EXPERIMENTAL
Intervention: Long leg TED hose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sequential compression devices (SCD)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (96 patients)
Number of subjects: 77
Study: 3782631

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 8341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8341
Study: 31046528

Group type: EXPERIMENTAL
Intervention: Acquaintance sexual violence scenario
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Victims of sexual violence
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Nonvictims with stronger just-world beliefs
Number of subjects: 296

Group type: COMPARATOR
Intervention: Stranger sexual violence scenario
Number of subjects: 296
Study: 29431272

Group type: EXPERIMENTAL
Intervention: Prolonged sitting
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sitting interrupted by regular brief activity breaks
Number of subjects: 62
Study: 27581575

Group type: EXPERIMENTAL
Intervention: Intensive counseling + mass media + community mobilization (IPC + MM + CM)
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Standard nutrition counseling + less intensive mass media + community mobilization (nonintensive)
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Intensive group
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Nonintensive group
Number of subjects: 2200
Study: 24529603

Group type: EXPERIMENTAL
Intervention: Multi-convergent therapy (MCT) for 16 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 22378825

Group type: EXPERIMENTAL
Intervention: Fetal ethanol exposure (administered to dams through a liquid diet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capsaicin (to target TrpV1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mustard oil (to target TrpA1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (ad libitum access to an iso-caloric iso-nutritive liquid diet)
Number of subjects: 0
Study: 20470336

Group type: EXPERIMENTAL
Intervention: Midazolam (0.5 mg x kg(‐1) in 5 ml of honey)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Midazolam-Ketamine (0.25 mg x kg(‐1) midazolam mixed with 1 mg x kg(‐1) ketamine in 5-ml honey)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (5-ml honey alone)
Number of subjects: 92
Study: 18257184

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with TDP radiation
Number of subjects: 158

Group type: COMPARATOR
Intervention: L-Dopa (Control)
Number of subjects: 158
Study: 16416346

Group type: EXPERIMENTAL
Intervention: T4 treatment for hypothyroidism
Number of subjects: 85

Group type: COMPARATOR
Intervention: Normal individuals with the same TSH levels
Number of subjects: 85
Study: 12801161

Group type: EXPERIMENTAL
Intervention: Sertraline at a dosage of 200 mg/day during the 8-week open-label extension phase.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sertraline at a dosage of 100 mg/day during the acute phase.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonresponders from the acute phase.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both phases (acute and extension).
Number of subjects: 0
Study: 10929571

Group type: EXPERIMENTAL
Intervention: bupropion-SR 150 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: bupropion-SR 300 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: bupropion-SR
Number of subjects: 30
Study: 8842507

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone (2 mg/kg iv over 10 minutes followed by 0.007 mg/kg/min)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Intravenous placebo (0.9% saline solution)
Number of subjects: 182
Study: 1352662

Group type: EXPERIMENTAL
Intervention: esmolol 2 mg.kg‐1
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: nitroglycerin 3 micrograms.kg‐1
Number of subjects: 82

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 82
Study: 6378231

Group type: EXPERIMENTAL
Intervention: Aspirin 1200 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30979733

Group type: EXPERIMENTAL
Intervention: Gradient Boosting Machine (GBM)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Random Forest (RF)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Ordinal RF classifier
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Unsupervised clustering analysis
Number of subjects: 334
Study: 30632328

Group type: EXPERIMENTAL
Intervention: Simultaneous ventriculoperitoneal (VP) shunting
Number of subjects: 98

Group type: COMPARATOR
Intervention: Delayed ventriculoperitoneal (VP) shunting
Number of subjects: 98
Study: 27343417

Group type: COMPARATOR
Intervention: Watchman device
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 407
Study: 25465416

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 26449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26449
Study: 22441756

Group type: EXPERIMENTAL
Intervention: Third Eye Retroscope (TER)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Adenomas in the left colon
Number of subjects: 406
Study: 20451694

Group type: COMPARATOR
Intervention: Normal BMI (18.5 to 24.9 kg/m²)
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Overweight (BMI 25.0 to 29.9 kg/m²)
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Obese (BMI ≥30.0 kg/m²)
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1703
Study: 18217149

Group type: EXPERIMENTAL
Intervention: 150 mg/day clopidogrel
Number of subjects: 40

Group type: COMPARATOR
Intervention: 75 mg/day clopidogrel
Number of subjects: 40
Study: 15713204

Group type: EXPERIMENTAL
Intervention: Fresnel prisms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gottlieb Visual Field Awareness System
Number of subjects: 0
Study: 12799117

Group type: EXPERIMENTAL
Intervention: Olive oil formulation dentifrice
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoride‐matched control
Number of subjects: 20
Study: 11102258

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 0
Study: 8795167

Group type: EXPERIMENTAL
Intervention: Original readings of carotid IMT measurements at baseline
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Original readings of carotid IMT measurements at 36 months
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: 3-year change in carotid IMT measurements
Number of subjects: 919

Group type: COMPARATOR
Intervention: Rereadings of carotid IMT measurements
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficients between original readings and rereadings
Number of subjects: 919
Study: 1735697

Group type: EXPERIMENTAL
Intervention: AK-2123 (3-nitro-1,2,4-triazole) intratumoral injection at 1% and 2%
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: AK-2123 (3-nitro-1,2,4-triazole) intratumoral injection
Number of subjects: 80
Study: 6365350

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg orally every 4 hr for 14 days)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo plus standard care
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 31473065

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention delivered by community health workers with tailored text messages for 18 months
Number of subjects: 1954

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1954

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1954
Study: 30103622

Group type: EXPERIMENTAL
Intervention: Patiromer (8.4 g/d to start, adjusted to maintain serum potassium of 3.8 to 5.0 mEq/L)
Number of subjects: 112
Study: 26987723

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 23915056

Group type: EXPERIMENTAL
Intervention: ITC representation of objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit behavioral ratings of semantic similarity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computational measures of semantic similarity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Earlier visual areas (V1)
Number of subjects: 0
Study: 22402220

Group type: EXPERIMENTAL
Intervention: Supervised resistance training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 15
Study: 20210620

Group type: EXPERIMENTAL
Intervention: PC17 jacket
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: gel jacket
Number of subjects: 12

Group type: COMPARATOR
Intervention: no jacket (control)
Number of subjects: 12
Study: 18538692

Group type: EXPERIMENTAL
Intervention: Anti-NB treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16006454

Group type: EXPERIMENTAL
Intervention: 150 mg/day acarbose
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10049281

Group type: EXPERIMENTAL
Intervention: Stavudine (40 mg twice daily) in combination with one to three other drugs for opportunistic infections
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stavudine (40 mg twice daily)
Number of subjects: 10
Study: 8657058

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg on the first day, then 100 mg daily for 13 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (same parodontal therapy without doxycycline)
Number of subjects: 30
Study: 2189989

Group type: EXPERIMENTAL
Intervention: Naftifine cream 1%
Number of subjects: 57

Group type: COMPARATOR
Intervention: Clotrimazole cream 1%
Number of subjects: 57
Study: 348309

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (CY), 60 mg/kg iv, given on Days 1 and 2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (CY), 60 mg/kg iv, given on Days 1 and 8
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: COMB (CY, 800 mg/m2; vincristine [Oncovin], 1.4 mg/m2; methotrexate, 20 mg/m2; and BCNU, 60 mg/m2)
Number of subjects: 23
Study: 31331099

Group type: EXPERIMENTAL
Intervention: Whey protein (WHEY)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nonessential amino acids blend (NEAA)
Number of subjects: 22
Study: 28583057

Group type: EXPERIMENTAL
Intervention: Auricular acupressure at shen men, point zero, and subcortex points
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 0
Study: 26252777

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LSI) plus Berberine (BBR) 0.5g tid for 16 weeks
Number of subjects: 184

Group type: COMPARATOR
Intervention: Lifestyle intervention (LSI)
Number of subjects: 184
Study: 24146421

Group type: EXPERIMENTAL
Intervention: Mydriasert (conjunctival insert)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Tropicamide/phenylephrine eye drops
Number of subjects: 10

Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 10
Study: 20970517

Group type: EXPERIMENTAL
Intervention: BD+ICS
Number of subjects: 22

Group type: COMPARATOR
Intervention: PL
Number of subjects: 22
Study: 17376722

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI 80/4.5 microg
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol DPI 80/4.5 microg
Number of subjects: 622

Group type: COMPARATOR
Intervention: Budesonide pMDI 100 microg
Number of subjects: 622
Study: 16615717

Group type: EXPERIMENTAL
Intervention: Sample nonwords presented in groups with the same word rules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grouping of word exemplars by category
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthographic characteristics of words
Number of subjects: 0
Study: 12898557

Group type: EXPERIMENTAL
Intervention: Anorexia Nervosa (AN)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Major Depressive Disorder (MDD)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Anorexia Nervosa (AN) subtypes
Number of subjects: 98
Study: 11107508

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of dipyridamole (0.5 mg/kg body weight)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 30
Study: 9236429

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of Ang II
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 8
Study: 8026410

Group type: EXPERIMENTAL
Intervention: High VNS
Number of subjects: 67

Group type: COMPARATOR
Intervention: Low VNS to High VNS
Number of subjects: 67
Study: 2690334

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg daily
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 164
Study: 970899

Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 60

Group type: COMPARATOR
Intervention: methohexitone
Number of subjects: 60
Study: 31201202

Group type: EXPERIMENTAL
Intervention: eCARE programme (SMS support)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 424
Study: 29485790

Group type: EXPERIMENTAL
Intervention: Paracetamol administered through patient-controlled analgesia (PCA) pump
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracetamol administered intermittently
Number of subjects: 0
Study: 25344090

Group type: EXPERIMENTAL
Intervention: 250 mg AA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 500 mg AA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1000 mg AA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 hour premeal 1000 mg AA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 hours postmeal 1000 mg AA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 hours apart meals 1000 mg AA
Number of subjects: 30
Study: 23497514

Group type: EXPERIMENTAL
Intervention: A/A genotype at age 4
Number of subjects: 963

Group type: EXPERIMENTAL
Intervention: A/A genotype at age 8
Number of subjects: 963

Group type: EXPERIMENTAL
Intervention: At least one copy of the A allele in schoolchildren sample
Number of subjects: 963
Study: 21806789

Group type: EXPERIMENTAL
Intervention: 9-week high intensity progressive resistance training (HIPRT) program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care (UNT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy matched control subjects (CON) completing the same HIPRT program
Number of subjects: 30